跳至主要内容
临床试验/NCT03406533
NCT03406533终止不适用

The Effect and Safety of Different Sedation Strategies for Diagnostic Bronchoscopy

Changhai Hospital1 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2018年2月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
入组人数
28
试验地点
1
主要终点
Cough score

研究概览

简要总结

Diagnostic bronchoscopy is an invasive procedure performed to diagnose respiratory diseases. But pain has been complained by most of the patients receiving such procedures. Sedation or anesthesia was required by both of the patients and bronchoscopists. Unfortunately, no consensus has been made upon the sedation strategies. Multiple sedation approaches have been applied, such as midazolam and fentanyl, remifentanil and propofol, dexmedetomidine and propofol. The present study was designed to compare these protocols in sedation for diagnostic bronchoscopy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Scheduled for flexible diagnostic bronchoscopy
  • Adult patients aged 18 to 65 years
  • American Society of Anesthesiologists (ASA) Physical Status Classification I-II
  • BMI 18.5-25kg/m2
  • Subjects provide informed consent

排除标准

  • Severe airway obstruction
  • Coagulation disorder
  • Repeat bronchoscopy (more than 3 times)
  • Severe liver and renal dysfunction
  • Cardiovascular and cerebrovascular diseases
  • Pregnancy
  • Chronic opioid user
  • Drug abusers or addicts

研究组 & 干预措施

Group DR

Experimental

Sedated with midazolam, dexmedetomidine and remifentanil

干预措施: Remifentanil (Drug)

Group F

Experimental

Sedated with midazolam and fentanyl

干预措施: Midazolam (Drug)

Group F

Experimental

Sedated with midazolam and fentanyl

干预措施: Fentanyl (Drug)

Group DR

Experimental

Sedated with midazolam, dexmedetomidine and remifentanil

干预措施: Midazolam (Drug)

Group DR

Experimental

Sedated with midazolam, dexmedetomidine and remifentanil

干预措施: Dexmedetomidine (Drug)

Group DF

Experimental

Sedated with midazolam, dexmedetomidine and fentanyl

干预措施: Midazolam (Drug)

Group DF

Experimental

Sedated with midazolam, dexmedetomidine and fentanyl

干预措施: Dexmedetomidine (Drug)

Group DF

Experimental

Sedated with midazolam, dexmedetomidine and fentanyl

干预措施: Fentanyl (Drug)

Group PR

Experimental

Sedated with midazolam, propofol and remifentanil

干预措施: Midazolam (Drug)

Group PR

Experimental

Sedated with midazolam, propofol and remifentanil

干预措施: Remifentanil (Drug)

Group PR

Experimental

Sedated with midazolam, propofol and remifentanil

干预措施: Propofol (Drug)

结局指标

主要结局

Cough score

时间窗: From the completion of local anesthesia with lidocaine to the completion of bronchoscopy procedure, assessed up to 2 hours

Cough score across the procedure will be classified into 4 degree (1-4) as follows. 1 = none, 2 = one gag or cough only, 3 = \>1 gag or cough, but acceptable conditions, 4 = unacceptable conditions

次要结局

  • Body movement(From the completion of local anesthesia with lidocaine to the completion of bronchoscopy procedure, assessed up to 2 hours)
  • Satisfaction score of the patients and bronchoscopists(Across the procedure, assessed up to 2 hours)
  • Amount of the rescue use of propofol(After sedation induction, assessed up to 2 hours)
  • Recovery time(After termination of the sedation medication, assessed up to 2 hours)
  • Prevalence of the side effects of respiratory and circulatory system(Across the sedation duration, assessed up to 2 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jia-feng Wang

MD

Changhai Hospital

研究点 (1)

Loading locations...

相似试验

Sedation Strategies for Diagnostic Bronchoscopy | 临床试验